Home > Income Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Operating Profit

    Back to Income Statement
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Operating Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Operating Profit (Excl OI) ₹1,195 Cr₹1,635 Cr₹2,320 Cr₹2,084 Cr₹1,698 Cr

What is the latest Operating Profit of GLENMARK PHARMACEUTICALS ?

The latest Operating Profit ratio of GLENMARK PHARMACEUTICALS is ₹1,195 Cr based on Mar2025 Consolidated results.
Year Operating Profit
Mar2025₹1,195 Cr
Mar2024₹1,635 Cr
Mar2023₹2,320 Cr
Mar2022₹2,084 Cr
Mar2021₹1,698 Cr

How is Operating Profit of GLENMARK PHARMACEUTICALS Trending?

Years Operating Profit % Change
Mar2025 ₹1,195 Cr
-26.89
Mar2024 ₹1,635 Cr
-29.53
Mar2023 ₹2,320 Cr
11.32
Mar2022 ₹2,084 Cr
22.75
Mar2021 ₹1,698 Cr -

Compare Operating Profit of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹56,764.5 Cr -3.2% 1.3% 30.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,019.0 Cr -3.5% -5.4% -3.2% Stock Analytics
DIVIS LABORATORIES ₹168,752.0 Cr -3.6% 0.2% 11.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,542.0 Cr -0.5% 5.9% 20.3% Stock Analytics
CIPLA ₹115,883.0 Cr -1.8% -4.8% -1.5% Stock Analytics
DR REDDYS LABORATORIES ₹99,024.7 Cr -1.7% -7.3% -12.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-3.2%

1.3%

30.4%

SENSEX

-1.9%

-2.2%

7.4%


You may also like the below Video Courses